NDC 50242-210

Gavreto

Pralsetinib

Gavreto is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Pralsetinib.

Product ID50242-210_05cc6c61-4048-4f99-88e3-f01cb828b21c
NDC50242-210
Product TypeHuman Prescription Drug
Proprietary NameGavreto
Generic NamePralsetinib
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-09-04
Marketing CategoryNDA /
Application NumberNDA213721
Labeler NameGenentech, Inc.
Substance NamePRALSETINIB
Active Ingredient Strength100 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50242-210-12

1 BOTTLE in 1 CARTON (50242-210-12) > 120 CAPSULE in 1 BOTTLE
Marketing Start Date2021-07-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Gavreto" or generic name "Pralsetinib"

NDCBrand NameGeneric Name
50242-210GavretoPralsetinib
72064-210GAVRETOpralsetinib

Trademark Results [Gavreto]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GAVRETO
GAVRETO
90546447 not registered Live/Pending
Blueprint Medicines Corporation
2021-02-25
GAVRETO
GAVRETO
90025140 not registered Live/Pending
Blueprint Medicines Corporation
2020-06-29
GAVRETO
GAVRETO
88492520 not registered Live/Pending
Blueprint Medicines Corporation
2019-06-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.